(Q34464972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

cost-effectiveness analysis

5 December 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

A Bagust

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A Haycox

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T Walley

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

601-615

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

Causes and consequences of oral contraceptive noncompliance.

5 December 2019

cites work

1 reference

Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies

21 January 2018

1 reference

Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens

21 January 2018

1 reference

The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

The cost-effectiveness of different management strategies for patients on chronic warfarin therapy

21 January 2018

1 reference

Cost analysis of once-daily ISMN versus twice-daily ISMN or transdermal patch for nitrate prophylaxis.

21 January 2018

1 reference

Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis

21 January 2018

1 reference

Perimenopausal bone density screening--will it help prevent osteoporosis?

21 January 2018

1 reference

Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model

21 January 2018

1 reference

The cost-effectiveness of the nicotine transdermal patch for smoking cessation.

21 January 2018

1 reference

Primary non-compliance with prescribed medication in primary care

21 January 2018

1 reference

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

21 January 2018

1 reference

Drug compliance in therapeutic trials: a review.

21 January 2018

1 reference

Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs.

21 January 2018

1 reference

Generalisation from phase III clinical trials: survival, quality of life, and health economics.

21 January 2018

1 reference

Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

21 January 2018

1 reference

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

21 January 2018

1 reference

A cost-effectiveness analysis of typhoid fever vaccines in US military personnel

21 January 2018

1 reference

Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis

21 January 2018

1 reference

Noncompliance with antihypertensive therapy. Economic consequences

21 January 2018

1 reference

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

21 January 2018

1 reference

Preventive Therapy for Tuberculosis in HIV-Infected Persons Analysis of Policy Options Based on Tuberculin Status and CD4 + Cell Count

21 January 2018

1 reference

Noncompliance may cause half of antihypertensive drug "failures"

21 January 2018

1 reference

Erratic patient compliance with prescribed drug regimens: target for drug delivery systems

21 January 2018

1 reference

Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis

21 January 2018

1 reference

Cost-effectiveness analysis of treatments to reduce cholesterol levels, blood pressure and smoking for the prevention of coronary heart disease: evaluative study carried out in Spain

21 January 2018

1 reference

The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.

21 January 2018

1 reference

Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy

21 January 2018

1 reference

Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria

21 January 2018

1 reference

Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada

21 January 2018

1 reference

Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings

21 January 2018

1 reference

Persistence of use of lipid-lowering medications: a cross-national study

21 January 2018

1 reference

Cost effectiveness of hepatitis A prevention in France

21 January 2018

1 reference

Apparent discontinuation rates in patients prescribed lipid-lowering drugs.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Underutilization of antihypertensive drugs and associated hospitalization

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEC.609

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11747044%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference